ArticlePharmacology research & perspectives2020

Pharmacological characterization of a novel, potent, selective, and orally active fatty acid amide hydrolase inhibitor, PKM-833 [(R)-N-(pyridazin-3-yl)-4-(7-(trifluoromethyl)chroman-4-yl)piperazine-1-carboxamide] in rats: Potential for the treatment of inflammatory pain.

Toshiya Endo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.